HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry-Reference-Cited by-同舟云学术

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

Published:2002-10-31 Issue:10 Volume:95 Page:2068-2075
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Quenneville Louise A.,Phillips Kelly-Anne,Ozcelik Hilmi,Parkes Robert K.,Knight Julia A.,Goodwin Pamela J.,Andrulis Irene L.,O'Malley Frances P.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases

2. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

3. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

4. The frequency of founder mutations in theBRCA1,BRCA2, andAPC genes in australian Ashkenazi Jews

5. Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCT domains as chromatin readers: Structure, function, and clinical implications;Chromatin Readers in Health and Disease;2024

2. Survival outcomes of patients with HER2/neu‐positive breast cancer with germline BRCA mutations;Cancer;2023-12-15

3. Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis;ESMO Open;2022-08

4. Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study;European Journal of Breast Health;2021-04-01

5. The role of pathologists in recognition of morphologic and biologic features of genetically mutated breast cancer;The Breast Journal;2020-08